Kemarin, Prilenia menyelenggarakan webinar yang memperbarui uji coba Fase III dengan Pridopidin. Terima kasih kepada semua orang yang bergabung dan terima kasih khusus kepada pembicara kami, Michael Hayden, Andrew Feigin, Ralf Reilman dan Anne Rosser dan juga kepada Dina de Sousa untuk Asosiasi Huntington Eropa. Nantikan untuk melihat lebih banyak acara selama Bulan Kesadaran Mei! 
December 2, 2024 – PTC to receive $1.0B in cash at closing –– PTC is eligible to receive up to $1.9B in development, regulatory and sales milestones –– PTC to share profits in the U.S. and tiered double-digit royalties on ex-U.S. net Baca lebih lanjut...
The Phase 2 DIMENSION Study did not meet its primary endpoint Dalzanemdor was generally well-tolerated; no new safety signals were observed Based on these data, the Company does not plan further development of dalzanemdor CAMBRIDGE, Baca lebih lanjut...
PRESS RELEASE – October 25, 2024, Moscow, Idaho, USAWe are pleased to announce the launch of a new book about Huntington’s disease (HD) called, Livable Lives: Conversations with the Huntington’s Disease Community, by Christy Dearien, Baca lebih lanjut...
Indonesian 
English 
Arabic 
Bulgarian 
Chinese 
Czech 
Danish 
Dutch 
Estonian 
Finnish 
French 
German 
Greek 
Hungarian 
Italian 
Japanese 
Latvian 
Lithuanian 
Polish 
Portuguese 
Romanian 
Russian 
Slovak 
Slovenian 
Spanish 
Swedish 
Turkish 
Ukrainian
0 Komentar